News tagged with 'Calcium'

The jury is still out on a new, controversial osteoporosis drug Pfizer hopes to market. Fablyn may have some additional risk for cancer and was rejected by the FDA three years ago. Approval could mean $500 million a year for Pfizer. 

In a major breakthrough, scientists have shown that men with high levels of calcium in their blood are almost three times as likely to be killed by fatal prostate cancer.